MicroRNAs, Parkinson's Disease, and Diabetes Mellitus

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Apr 3

PMID 33799467

Citations 16

Authors

Hsiuying Wang

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder that affects 1% of the population over the age of 60. Diabetes Mellitus (DM) is a metabolic disorder that affects approximately 25% of adults over the age of 60. Recent studies showed that DM increases the risk of developing PD. The link between DM and PD has been discussed in the literature in relation to different mechanisms including mitochondrial dysfunction, oxidative stress, and protein aggregation. In this paper, we review the common microRNA (miRNA) biomarkers of both diseases. miRNAs play an important role in cell differentiation, development, the regulation of the cell cycle, and apoptosis. They are also involved in the pathology of many diseases. miRNAs can mediate the insulin pathway and glucose absorption. miRNAs can also regulate PD-related genes. Therefore, exploring the common miRNA biomarkers of both PD and DM can shed a light on how these two diseases are correlated, and targeting miRNAs is a potential therapeutic opportunity for both diseases.

Citing Articles

Research progress of non-coding RNA regulating the role of PANoptosis in diabetes mellitus and its complications.

Han G, Hu K, Luo T, Wang W, Zhang D, Ouyang L Apoptosis. 2025; .

PMID: 39755822 DOI: 10.1007/s10495-024-02066-w.

Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson's Disease.

Tanvir A, Jo J, Park S Cells. 2024; 13(22).

PMID: 39594624 PMC: 11592965. DOI: 10.3390/cells13221876.

The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?.

Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, Chodari L, Nezhadshahmohammad F AIMS Neurosci. 2024; 11(3):374-397.

PMID: 39431275 PMC: 11486621. DOI: 10.3934/Neuroscience.2024023.

Bibliometric analysis of microRNAs and Parkinson's disease from 2014 to 2023.

Chen L, Chen J, Weng W, Wu M, Zhou X, Yan P Front Neurol. 2024; 15:1466186.

PMID: 39385824 PMC: 11462628. DOI: 10.3389/fneur.2024.1466186.

Global genomic profile of hippocampal endothelial cells by single-nuclei RNA sequencing in female diabetic mice is associated with cognitive dysfunction.

Milenkovic D, Nuthikattu S, Norman J, Villablanca A Am J Physiol Heart Circ Physiol. 2024; 327(4):H908-H926.

PMID: 39150395 PMC: 11901383. DOI: 10.1152/ajpheart.00251.2024.

References

Chen Q, Qiu F, Zhou K, Matlock H, Takahashi Y, Rajala R . Pathogenic Role of in Diabetic Retinopathy Through Downregulation of PPARα. Diabetes. 2017; 66(6):1671-1682. PMC: 5440012. DOI: 10.2337/db16-1246. View

Dong Y, Han L, Xu Z . Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease. Mol Med. 2018; 24(1):61. PMC: 6263543. DOI: 10.1186/s10020-018-0059-9. View

Hu D, Wang Y, Zhang H, Kong D . Identification of miR-9 as a negative factor of insulin secretion from beta cells. J Physiol Biochem. 2018; 74(2):291-299. DOI: 10.1007/s13105-018-0615-3. View

Zhang H, Liu J, Qu D, Wang L, Luo J, Lau C . Inhibition of miR-200c Restores Endothelial Function in Diabetic Mice Through Suppression of COX-2. Diabetes. 2016; 65(5):1196-207. DOI: 10.2337/db15-1067. View

Arshad A, Sulaiman S, Saperi A, Jamal R, Mohamed Ibrahim N, Abdul Murad N . MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease. Front Mol Neurosci. 2017; 10:352. PMC: 5671573. DOI: 10.3389/fnmol.2017.00352. View

Fu J, Peng L, Tao T, Chen Y, Li Z, Li J . Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomed Pharmacother. 2019; 119:109409. DOI: 10.1016/j.biopha.2019.109409. View

Zhang X, Yang R, Hu B, Lu P, Zhou L, He Z . Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease. Front Cell Neurosci. 2017; 11:170. PMC: 5481393. DOI: 10.3389/fncel.2017.00170. View

Jansson M, Lund A . MicroRNA and cancer. Mol Oncol. 2012; 6(6):590-610. PMC: 5528350. DOI: 10.1016/j.molonc.2012.09.006. View

Sekar D, Venugopal B, Sekar P, Ramalingam K . Role of microRNA 21 in diabetes and associated/related diseases. Gene. 2016; 582(1):14-8. DOI: 10.1016/j.gene.2016.01.039. View

10.

Massaro J, Polli C, Silva M, Alves C, Passos G, Sakamoto-Hojo E . Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus. Mol Cell Endocrinol. 2019; 490:1-14. DOI: 10.1016/j.mce.2019.03.008. View

11.

Yue X, Li H, Yan H, Zhang P, Chang L, Li T . Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies. Medicine (Baltimore). 2016; 95(18):e3549. PMC: 4863785. DOI: 10.1097/MD.0000000000003549. View

12.

Gasser T . Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review. J Parkinsons Dis. 2015; 5(2):209-15. PMC: 4923738. DOI: 10.3233/JPD-140507. View

13.

Dawson T, Dawson V . The role of parkin in familial and sporadic Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S32-9. PMC: 4115293. DOI: 10.1002/mds.22798. View

14.

Sharma S, Chorell E, Steneberg P, Vernersson-Lindahl E, Edlund H, Wittung-Stafshede P . Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner. Sci Rep. 2015; 5:12531. PMC: 4521159. DOI: 10.1038/srep12531. View

15.

Chen Y, Zheng J, Su L, Chen F, Zhu R, Chen X . Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson's Disease. Front Aging Neurosci. 2020; 12:210. PMC: 7360355. DOI: 10.3389/fnagi.2020.00210. View

16.

Assmann T, Recamonde-Mendoza M, Punales M, Tschiedel B, Canani L, Crispim D . MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis. Diabetes Res Clin Pract. 2018; 141:35-46. DOI: 10.1016/j.diabres.2018.03.044. View

17.

Zhou J, Zhao Y, Li Z, Zhu M, Wang Z, Li Y . miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling. Pharmacol Res. 2020; 160:105197. DOI: 10.1016/j.phrs.2020.105197. View

18.

Cui C, Ye X, Chopp M, Venkat P, Zacharek A, Yan T . miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats. Stem Cells Transl Med. 2016; 5(12):1656-1667. PMC: 5189645. DOI: 10.5966/sctm.2015-0349. View

19.

Wang H . Predicting cancer-related MiRNAs using expression profiles in tumor tissue. Curr Pharm Biotechnol. 2014; 15(5):438-44. DOI: 10.2174/1389201015666140519121255. View

20.

Demirsoy I, Yolal Ertural D, Balci S, Cinkir U, Sezer K, Tamer L . Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes. J Med Biochem. 2018; 37(4):499-506. PMC: 6298473. DOI: 10.2478/jomb-2018-0009. View